Mark E. Fleury

Autologous Chemotaxis as a Mechanism of Tumor Cell Homing to Lymphatics via Interstitial Flow and Autocrine CCR7 Signaling

Jacqueline D. Shields, Mark E. Fleury, Carolyn Yong et al. · Cancer Cell · 2007 · 549 citations · Full text

Medicine, Cell Biology, Oncology +17

Synergy between interstitial flow and VEGF directs capillary morphogenesis <i>in vitro</i> through a gradient amplification mechanism

Cara‐Lynn E. Helm, Mark E. Fleury, Andreas H. Zisch et al. · Proceedings of the National Academy of Sciences · 2005 · 270 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +17

Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation

Joseph M. Unger, Dawn L. Hershman, Mark E. Fleury et al. · JAMA Oncology · 2019 · 183 citations

Medicine, Oncology, Cancer Control +15

Autologous Morphogen Gradients by Subtle Interstitial Flow and Matrix Interactions

Mark E. Fleury, Kendrick C. Boardman, Melody A. Swartz · Biophysical Journal · 2006 · 162 citations · Full text

Life Sciences, Bioengineering, Cell Biology +16

National Estimates of the Participation of Patients With Cancer in Clinical Research Studies Based on Commission on Cancer Accreditation Data

Joseph M. Unger, Lawrence N. Shulman, Matthew A. Facktor et al. · Journal of Clinical Oncology · 2024 · 90 citations · Full text

Medicine, Biostatistics, Oncology +17